Background. The cooccurrence of HIV infection and severe malnutrition contributes to high rates of morbidity and mortality among children in resourcelimited settings. Lactosefree, readytouse therapeutic feeds (RUTFs) may be most appropriate in this population because of underlying mucosal damage secondary to inflammation and infection. Objectives. To describe the effect of lactosefree RUTFs on the growth parameters of severely malnourished HIVinfected children in Durban, South Africa (SA). Methods. This was a prospective, observational study of nutritional recovery in HIVinfected, severely malnourished children, aged 6 months to 5 years, who received lactosefree RUTFs following admission to King Edward VIII Hospital in Durban, SA. The primary outcome was nutritional recovery, defined as 15% weight gain from enrolment to end of study. Secondary outcomes included zscores for weightforheight, weightforage, heightforage, triceps skinfold thickness (SFT) and subscapular SFT calculated at baseline and 7, 14, 30 and 45 days after admission. Univariate analysis was done to compare outcomes among antiretroviral therapy (ART)naive and ART experienced children; the effect of ART on nutritional recovery was evaluated in a logistic regression model. Results. A significant improvement in most nutritional parameters was found at 45 days; 59% of children attained nutritional recovery. There was no significant difference in the proportion of children reaching recovery based on ART status at admission (p=0.08). Conclusion. Lactosefree formula feeds may be an effective strategy for nutritional rehabilitation of severely malnourished and HIV infected children in resourcelimited settings. It remains to be determined how ART initiation affects nutritional recovery in these children.
Severe acute malnutrition (SAM) affects 13 million child ren under the age of 5 years and leads to 1 2 million preventable paediatric deaths annually. [1] The World Health Organization (WHO) defines SAM as the presence of at least one of: (i) weightforheight more than 70% below the agespecific median or three or more standard deviations (SDs) below the mean in a normally distributed population; (ii) midupper arm circumference <115 mm; or (iii) the presence of bilateral lower extremity pitting oedema of nutritional origin. [2, 3] In developing countries, there is often an overlap between HIV infection and malnutrition. The prevalence of SAM is approximately threefold higher in HIVinfected than HIVuninfected children, [4] and SAM is often the precipitating event that prompts healthcare seeking behaviour among HIVinfected children. Cooccurrence of SAM and HIV increases morbidity, including stunted physical and cognitive development, and mortality. [5, 6] The WHO recommends the use of two specific formula diets as treatment for SAM: the F75 (75 kcalth or 315 kJ/100 mL) during the initial phase of treatment and the F100 (100 kcal th or 420 kJ/100 mL) during the rehabilitation phase after the child's appetite has returned. [2] Countries such as South Africa (SA) have developed local, readytouse therapeutic feeds (RUTFs) similar in nutritional composition to the WHOrecommended F100 formula. Unlike the F100, RUTFs are not water based, thus minimising potential contamination or barriers associated with water acquisition. [6, 7] Furthermore, the WHOrecommended feeds used to treat SAM are high in lactose and may not be optimal for HIVinfected children who tend to present with diarrhoea and malabsorption. Few studies have investigated the effect of the local and lactosefree RUTFs on the growth responses and nutritional recovery of severely malnourished HIVinfected children. [8] Our study describes the effect of a lactosefree RUTF on growth responses of severely malnourished HIVinfected children in Durban, SA.
Methods

Patients
Children admitted to the King Edward VIII Hospital paediatric wards were screened during two time periods: between February and March 2011 and between December 2011 and April 2012. Those who were 6 months 5 years of age, confirmed by HIV DNA polymerase chain reaction or HIV ELISA to be HIVinfected, and met the WHO definition of SAM, were eligible for enrolment in this prospective, observational study. Antiretroviral (ARV) therapy (ART)experienced children were defined as children who reported taking ARVs at the time of admission; ARTnaive children were defined as children who were not taking ARVs at admission. All patients were fed with an ageappropriate, lactosefree RUTF based on the postadmission day ( Table 1) .
Study procedures
Parents and guardians were approached to obtain written informed consent. The consent form was read to them in English or IsiZulu with the use of a translator. Measurements of weight, height, and biceps, triceps, subscapular and midthigh skinfold thickness (SFT), and demographic and pertinent clinical information were obtained at baseline and at days 7, 14, 30 and 45 post enrolment. SFT measurements were done with a Harpenden Skinfold Caliper (Baty International, UK). The study was approved by the Institutional Review Board of Columbia University and the Biomedical Research
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Ethics Committee at the University of KwaZuluNatal, as well as by the hospital management.
Statistical analysis
Indices of growth response and recovery were calculated using the WHO Anthro software (version 3.2.2). Zscores for weight forheight (WHZ), weightforage (WAZ), heightforage (HAZ), triceps SFT (TSZ) and subscapular SFT (SSZ) were calculated at baseline and at followup days 7, 14, 30 and 45. Nutritional recovery was defined as ≥15% weight gain from enrolment through to end of study period or by day 45. Data were captured in Microsoft Access (USA). A binary logistic regression model was applied to data, including age, gender, CD4 cell count and percentage, baseline weight, ART status at baseline, presence of pedal oedema and WHZ >70% as independent variables. Analysis was performed using SPSS version 19 (IBM, USA).
Results
Baseline demographics of participants are shown in Table 2 . Sixteen of 30 children had CD4% available at baseline. Of these, 12 (75%) were severely immunosuppressed (CD4% <15%). Of 30 children, eight had HIV1 viral loads available at baseline; median log10 HIV 1 RNA was 6.3 (interquartile range (IQR) 5.7 6.9). Fifteen out of 30 children (50.0%) were on ARVs at enrolment.
Baseline growth parameters for participants are shown in Table 2 . Mean baseline growth parameters indicated that the children were severely malnourished: mean (SD) WAZ -3.97 (1.0), mean WHZ -3.27 (1.1), mean TSZ -3.08 (1.2) and mean SSZ -3.95 (1.7). Twenty four of 30 had a WHZ <70% of the median, suggesting that this was more of an acute presentation of severe malnutrition rather than a chronic state where stunting would be more prevalent. Baseline comorbidities are shown in Table 3 .
Twentytwo of the 30 children had evaluations through to study end at day 45. Three died of opportunistic infections and five were lost to followup. Of the study subjects, 59.0% (n=13) attained nutritional recovery while 41.0% (n=9) remained malnourished. There was a significant improvement from baseline to day 45 (n=22 patients) in WAZ (1.34 (1.90), p=0.003), TSZ (1.43 (1.60), p=0.0005) and SSZ (2.02 (2.50), p=0.001), a trend to significance for WHZ (0.95 (2.20), p=0.060) and a statistically insignificant improvement for HAZ (0.76 (0.50), p=0.100). The mean rate of weight gain was 3.5 (6.9) g/kg/day but increased to 4.7 (5.0) g/kg/day after excluding the three deceased.
A comparison of baseline characteristics and clinical outcomes between ARTexperienced and ARTnaive children at the start of the study showed no significant differences (Table 4 ). However, in univariate analysis, ARTnaive children had a slightly higher likelihood of reaching nutritional recovery at day 45 (60% v. 40%; p=0.08) than children who were ARTexperienced. In logistic regression analysis, being ARTnaive at presentation was associated with nutritional recovery at day 45 (OR 2.25, p=0.465), although this was not statistically significant ( Table 5 ). Demographic factors, baseline weight, and CD4 cell percentage were not associated with nutritional recovery at day 45.
Discussion
Current WHO guidelines for the treatment of SAM do not make specific formula recommendations for refeeding children who are both severely malnourished and HIVinfected. With HIV infection, there is mucosal damage secondary to infection or inflammation leading to chronic diarrhoea, proteinlosing enteropathy, carbo hydrate deficiencies and fat malabsorption. [7] Therefore, lactosefree formulas may be appropriate alternatives for refeeding regimens in this population. Our results showed that HIVinfected children on lactose free RUTFs gained an average of 3.5 g/kg/day. This figure is similar to the average weight gain of severely malnourished children known to be HIVinfected in previous studies of lactosecontaining formulas recommended by the WHO. Ndekha et al. [9] and Sandige et al. [10] studied children in Malawi who were severely malnourished and HIV infected; both studies reported an average weight gain of 3.1 (2.7) g/kg/ day and 3.6 (4.7) g/kg/day, respectively. Our study showed that children refed with lactosefree RUTF gained weight in a similar fashion. However, our study was limited owing to policies of the institution that did not make it possible to directly compare lactosefree with lactose containing formulas. We were also limited by our inability to confirm the presence of lactose maldigestion in our patients at presentation. The WHO recommends that the minimum rate of weight gain at the end of a nutritional rehabilitation period should be 5.0 g/kg/ day. After excluding values for the deceased children, our mean weight gain increased to 4.7 g/kg/day, approaching WHOexpected rates. This occurred despite the expectation that severely malnourished children who are HIVinfected should gain less weight or gain less rapidly than a normally distributed population, given the malabsorptive state and mucosal damage created by HIV infection.
Even when using highenergy RUTFs to manage SAM in HIVinfected children, mortality rates of ~38% at 4 6 weeks are too high. [11] Our mortality rates were slightly lower. At the end of our 45day study period, three patients had died (10% of our study population). Although the use of RUTF diets has been shown to lead to significant and sustained weight gain in HIVinfected children, this improvement has not always been associated with recovery in CD4 cell count or improvement in survival. [11, 12] One major limitation of our study was that we were not able to track the changes in CD4 cell count and percentage in our patients to determine if there was any association between nutritional recovery and improvement in CD4 cell count or percentage.
We compared the baseline characteristics and clinical outcomes of children on ART and those not on ART prior to the study. We observed no statistically significant differences between the two groups, although this may be due to our small sample size. We also investigated the effect of concurrent ART use on attaining nutritional recovery using a multivariate logistic regression model. Based on this model, being ARTnaive during acute illness may have been associated with nutritional recovery, although this result did not reach statistical significance. We hypothesise that the acute state of severe malnutrition and the concurrent use of ART with associated gastrointestinal sideeffects could compound the malabsorptive state in the gastrointestinal tracts of these children, leading to suboptimal absorption of nutrients and ART. Other studies have shown that early initiation of ART leads to improved nutritional status in HIVinfected children. [1315] Further research needs to be conducted to determine the right timing for initiation of ART in severely malnourished and HIVinfected children.
Conclusion
Lactosefree formula feeds may be an effective strategy for nutritional rehabilitation of severely malnourished and HIVinfected children in resourcelimited settings. Future studies should directly compare the effectiveness of both types of formulas in promoting nutritional recovery and explore how the timing of ART initiation with respect to acute refeeding affects nutritional recovery in these children.
Table 4. A comparison of baseline characteristics and clinical outcomes in ARTexperienced and ART-naive children receiving ready-to-use lactose-free formula feeds
ART-experienced (N=15) ART-naive (N=15) p-value
Baseline characteristics Age (months), mean (SD, IQR) 17.6 (11.9, 9.4 
